Do We Need to Assess Quality-of-Life with Both the St George's Respiratory Questionnaire and the EuroQol 5-Dimension Questionnaire in a Clinical Study with an Economic Component: Insights from the REVOLENS Study in Severe Emphysema.
Julie BulseiJeanne PfisterSylvie LeroyJeanne Marie PerotinCoralie BarbeCharles Hugo MarquetteGaëtan DesleeIsabelle Durand Zaleskinull nullPublished in: International journal of chronic obstructive pulmonary disease (2020)
The use of both the EQ-5D and the SGRQ in a clinical study with an economic component is justified. Based on our results, the SGRQ should not be used to obtain a utility score to calculate the incremental cost-effectiveness ratio and conclude on the efficiency of an intervention in emphysema patients.
Keyphrases
- end stage renal disease
- chronic obstructive pulmonary disease
- newly diagnosed
- randomized controlled trial
- ejection fraction
- patient reported
- chronic kidney disease
- cross sectional
- peritoneal dialysis
- psychometric properties
- prognostic factors
- early onset
- patient reported outcomes
- cystic fibrosis
- respiratory tract